🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Gaddii Guddaa › Connecticut

Qorannoo klinikaalii Dhibee Gaddii Guddaa Connecticut keessatti

Qorannoo 16 Dhibee Gaddii Guddaa f Connecticut keessatti hirmaatuu jiru.

Magaalota Connecticut keessatti

Takkalaa qorannoo (Ingiliffa)

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06793397

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  • Yale University School of Medicine, New Haven
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07412756

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  • University of Connecticut Health Center, Farmington
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05850689

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

  • UConn Health Center, Farmington
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06559306

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  • Seaport Investigator Site, Cromwell
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07065240

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Institute of Living, Hartford
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07076407

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

  • University of Connecticut School of Medicine Psychiatry Department, Farmington
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06547489

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Ct Clinical Research Associates, Cromwell
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Cromwell
  • Neurocrine Clinical Site, Farmington
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT06966401

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, New Haven
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07196501

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

  • VA Connecticut Healthcare System, West Haven
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 21 hanga 65 · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT05786066

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

  • Yale University, New Haven
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT05915013

Imaging Depression in Parkinson's Disease

  • Yale University, New Haven
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT06402955

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

  • Hartford Hospital, Hartford
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 40 · Saalaa hunda · Haaromfame 10-Bit-2026 · NCT06740383

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

  • Autobahn Site #122, Cromwell
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT06633016

Study of ALTO-300 in MDD

  • Site 214, Norwalk
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ado-2025 · NCT05922878

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.